课题基金 / 基金详情

Investigating drug therapies for inherited and acquired long QT syndrome using iPSC-derived cardiomyocytes and zebrafish whole hearts as translational models

Investigating drug therapies for inherited and acquired long QT syndrome using iPSC-derived cardiomyocytes and zebrafish whole hearts as translational models
使用 iPSC 衍生的心肌细胞和斑马鱼全心作为转化模型研究遗传性和获得性长 QT 综合征的药物治疗
批准号：
372315
负责人：
Claydon Thomas W
金额：
$49.6万
依托单位：
Simon Fraser University (Burnaby, B.C.)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-09-01 至 2022-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=372315&lang=en
关键词：
Activator Drugs Crispr Genome Editing Electrophysiology Herg Potassium Channel Induced Pluripotent Stem Cells Long Qt Syndrome

项目摘要

项目成果

Claydon Thomas W的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Each heart beat is generated by a co-ordinated wave of electrical excitation that spreads across the heart muscle. Each wave causes the muscle to contract and pump blood in the circulation. The waves have to be tightly controlled so that the heart beats i
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism-based targeted rescue of hERG channel dysfunction in hiPSC-CMs
海外基金